During the past decade, Long Island Arthritis & Osteoporosis Care conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Long Island Arthritis & Osteoporosis Care" are "Gout" (2 trials), "Chronic Uncontrolled Gout" (1 trials) and "Uncontrolled Gout" (1 trials). Many other conditions were trialed in "Long Island Arthritis & Osteoporosis Care" in a lesser frequency.

Most popular intervention types in "Long Island Arthritis & Osteoporosis Care" are "Biological" (2 trials), "Dietary Supplement" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Pegloticase" (1 trials), "Pegloticase with MTX" (1 trials), "acetaminophen" (1 trials), "fexofenadine" (1 trials) and "folic acid" (1 trials). Other intervention names were less common.

The vast majority of trials in "Long Island Arthritis & Osteoporosis Care" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Long Island Arthritis & Osteoporosis Care". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Long Island Arthritis & Osteoporosis Care, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Long Island Arthritis & Osteoporosis Care, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".